傲农生物
(603363)
| 流通市值：70.41亿 | | | 总市值：89.58亿 |
| 流通股本：21.47亿 | | | 总股本：27.31亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 4,520,952,423.17 | 2,205,836,627.38 | 8,474,746,757.55 | 6,335,161,290.25 |
| 营业总成本 | 4,818,822,983.52 | 2,283,918,745.89 | 8,694,992,727.85 | 6,392,792,809.51 |
| 其他经营收益 | | | | |
| 营业利润 | -266,630,144.74 | -39,118,890.94 | 97,811,169.75 | 400,203,260.86 |
| 利润总额 | -262,419,746.96 | -37,992,427.99 | 105,339,496.21 | 411,906,851.31 |
| 净利润 | -271,700,904.73 | -42,822,270.79 | 89,408,894.36 | 439,170,633.46 |
| 每股收益 | | | | |
| 其他综合收益 | -432,302.04 | -238,306.09 | 910,416.14 | -623,386.56 |
| 综合收益总额 | -272,133,206.77 | -43,060,576.88 | 90,319,310.5 | 438,547,246.9 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,484,588,304.98 | 3,511,001,830.48 | 3,331,931,358.53 | 3,522,080,982.74 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,328,495,297.34 | 5,339,565,693.59 | 5,410,005,378.82 | 5,626,063,985.39 |
| 资产总计 | 8,813,083,602.32 | 8,850,567,524.07 | 8,741,936,737.35 | 9,148,144,968.13 |
| 流动负债: | | | | |
| 流动负债合计 | 3,915,442,743.17 | 3,777,584,192.62 | 3,565,938,399.52 | 3,446,794,455.55 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,555,662,303.51 | 1,563,446,190.44 | 1,595,795,125.52 | 1,916,185,118.87 |
| 负债合计 | 5,471,105,046.68 | 5,341,030,383.06 | 5,161,733,525.04 | 5,362,979,574.42 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,960,397,970.63 | 3,097,747,934.08 | 3,130,473,782.44 | 3,341,937,904.99 |
| 股东权益合计 | 3,341,978,555.64 | 3,509,537,141.01 | 3,580,203,212.31 | 3,785,165,393.71 |
| 负债和股东权益合计 | 8,813,083,602.32 | 8,850,567,524.07 | 8,741,936,737.35 | 9,148,144,968.13 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,539,151,911.84 | 2,143,722,217.1 | 8,788,391,512.16 | 6,183,352,836.02 |
| 经营活动现金流出小计 | 4,867,769,458.34 | 2,261,209,037.34 | 8,635,448,099.4 | 6,474,821,430.17 |
| 经营活动产生的现金流量净额 | -328,617,546.5 | -117,486,820.24 | 152,943,412.76 | -291,468,594.15 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 17,599,680.76 | 9,667,183.45 | 92,992,384.35 | 64,752,382.43 |
| 投资活动现金流出小计 | 92,081,515.03 | 53,665,802.98 | 264,040,962.3 | 198,360,042.39 |
| 投资活动产生的现金流量净额 | -74,481,834.27 | -43,998,619.53 | -171,048,577.95 | -133,607,659.96 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 448,838,600 | 114,560,200 | 393,696,848.26 | 302,194,811.68 |
| 筹资活动现金流出小计 | 281,282,592.47 | 172,945,913.49 | 960,445,419.76 | 655,721,088.06 |
| 筹资活动产生的现金流量净额 | 167,556,007.53 | -58,385,713.49 | -566,748,571.5 | -353,526,276.38 |
| 汇率变动对现金及现金等价物的影响 | -52,372.93 | -26,317.47 | -37,603.9 | -19,425.38 |
| 现金及现金等价物净增加额 | -235,595,746.17 | -219,897,470.73 | -584,891,340.59 | -778,621,955.87 |
| 期末现金及现金等价物余额 | 311,200,446.64 | 326,898,722.08 | 546,796,192.81 | 353,065,577.53 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -235,595,746.17 | - | -584,891,340.59 | - |